Loading company…
MicroCyto develops and produces synthetic biology compounds for use in several industries.
Established in 2021 and based in Beijing, China, MicroCyto develops and produces compounds using synthetic biology and low-carbon processes. Applications include pharmaceuticals, household chemicals, agriculture, food, feed, and materials; products include biologically synthesized mannitol and related compounds. The company has R&D and production bases in Qinhuangdao. In March 2026, it raised Series A+ funding from He'nan Investment Group to advance AI biological computing and R&D.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in